Abstract:Our findings provide a novel and effective combination strategy for increasing potent anthelmintic agent avermectin B1a production by enhancing supplies of both acyl‐CoA starter and extender units. We achieved significant increase of B1a titer in Streptomyces avermitilis WT and industrial strains by heterologous expression of assembled loading module‐extension module 7‐TE domain of meilingmycin polyketide synthase, inhibition of key nodes in FA synthesis and TCA cycle pathways using CRISPRi, and co‐overexpression of β‐oxidation pathway genes fadD and fadAB for increasing levels of 2‐methylbutyryl‐CoA, malonyl‐CoA, and methylmalonyl‐CoA precursors. Such precursor supply strategies can be readily adapted for overproduction of other polyketides. Avermectins (AVEs), a family of macrocyclic polyketides produced by Streptomyces avermitilis, have eight components, among which B1a is noted for its strong insecticidal activity. Biosynthesis of AVE "a" components requires 2‐methylbutyryl‐CoA (MBCoA) as starter unit, and malonyl‐CoA (MalCoA) and methylmalonyl‐CoA (MMCoA) as extender units. We describe here a novel strategy for increasing B1a production by enhancing acyl‐CoA precursor supply. First, we engineered meilingmycin (MEI) polyketide synthase (PKS) for increasing MBCoA precursor supply. The loading module (using acetyl‐CoA as substrate), extension module 7 (using MMCoA as substrate) and TE domain of MEI PKS were assembled to produce 2‐methylbutyrate, providing the starter unit for B1a production. Heterologous expression of the newly designed PKS (termed Mei‐PKS) in S. avermitilis wild‐type (WT) strain increased MBCoA level, leading to B1a titer 262.2 μg/mL – 4.36‐fold higher than WT value (48.9 μg/mL). Next, we separately inhibited three key nodes in essential pathways using CRISPRi to increase MalCoA and MMCoA levels in WT. The resulting strains all showed increased B1a titer. Combined inhibition of these key nodes in Mei‐PKS expression strain increased B1a titer to 341.9 μg/mL. Overexpression of fatty acid β‐oxidation pathway genes in the strain further increased B1a titer to 452.8 μg/mL – 8.25‐fold higher than WT value. Finally, we applied our precursor supply strategies to high‐yield industrial strain A229. The strategies, in combination, led to B1a titer 8836.4 μg/mL – 37.8% higher than parental A229 value. These findings provide an effective combination strategy for increasing AVE B1a production in WT and industrial S. avermitilis strains, and our precursor supply strategies can be readily adapted for overproduction of other polyketides.

Designed biosynthesis of 25-methyl and 25-ethyl ivermectin with enhanced insecticidal activity by domain swap of avermectin polyketide synthase

Enhancement of acyl‐CoA precursor supply for increased avermectin B1a production by engineering meilingmycin polyketide synthase and key primary metabolic pathway genes

[Controlled study of aprotinin in the treatment of acute pancreatitis].

Avermectin B1a production in Streptomyces avermitilis is enhanced by engineering aveC and precursor supply genes

Three new milbemycins from a genetically engineered strain S . avermitilis MHJ1011

Engineering of primary metabolic pathways for titer improvement of milbemycins in Streptomyces bingchenggensis

Streptomyces avermitilis MICNEMA2022: a new biorational strain for producing abamectin as an integrated nematode management agent

Synthesis, Characterization and Insecticidal Activity of Milbemycin Analogues

Daily isocenter correction with electromagnetic-based localization improves target coverage and rectal sparing during prostate radiotherapy.

Fabrication of an Effective Avermectin Nanoemulsion Using a Cleavable Succinic Ester Emulsifier.

The biosynthesis and bioactivity evaluation of the cytosine-substituted mildiomycin analogue (MIL-C) for controlling powder mildew

Raising the avermectins production in Streptomyces avermitilis by utilizing nanosecond pulsed electric fields (nsPEFs)

Research progress of avermectin: A minireview based on the structural derivatization of avermectin

Fabrication of Novel Avermectin Nanoemulsion Using a Polyurethane Emulsifier with Cleavable Disulfide Bonds.

Preparation and Controlled Release of Multifunctional Avermectin Nano-pesticide

Harnessing the intracellular triacylglycerols for titer improvement of polyketides in Streptomyces

Increased resistance to satiation in diazepam-treated pigs

Titer improvement of milbemycins via coordinating metabolic competition and transcriptional co‐activation controlled by Streptomyces antibiotic regulatory protein family regulator in Streptomyces bingchenggensis

Synthesis, antibacterial and antifungal activity of myricetin derivatives containing piperidine and amide fragments

Design, Synthesis, and Biological Activities of Milbemycin Analogues

Long-term Outcomes of Triple Arthrodesis in Cerebral Palsy Patients